Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Oral lichen planus is not linked to sex hormone levels.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Bidens pilosa L. extract effectively treats androgen deficiency dry eye in rats.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.